1. Home
  2. ADAG vs ALCO Comparison

ADAG vs ALCO Comparison

Compare ADAG & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.30

Market Cap

260.3M

Sector

Health Care

ML Signal

HOLD

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$39.10

Market Cap

305.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
ALCO
Founded
2011
1960
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.3M
305.0M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ADAG
ALCO
Price
$3.30
$39.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$8.25
$44.00
AVG Volume (30 Days)
310.1K
18.5K
Earning Date
04-01-2026
05-11-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$37.98
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$31.32
52 Week High
$4.85
$45.01

Technical Indicators

Market Signals
Indicator
ADAG
ALCO
Relative Strength Index (RSI) 36.27 28.52
Support Level $2.78 $37.19
Resistance Level $3.53 $42.13
Average True Range (ATR) 0.33 0.77
MACD -0.07 -0.28
Stochastic Oscillator 7.07 10.55

Price Performance

Historical Comparison
ADAG
ALCO

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

Share on Social Networks: